By TradeIndia Team in Manufacturers — 04 Jun 2022

Antacids Market Dynamics, Growth, Prospect, and Prediction 2022-2027

Antacids work by neutralizing gastric acid. They are widely used to neutralize stomach acid in instances where it is beneficial. For instance, heartburn is caused by acid reflux. The majority of the people who consume antacids do not experience any adverse side effects. Antacids are a type of drug that helps to reduce the amount of stomach acid. Aluminium hydroxide, magnesium carbonate, and magnesium trisilicate are all antacids. These are marketed as tablets and liquids under different brand names. Some antacids are coupled with a drug called simethicone, which aids in wind reduction (flatulence).

Many kinds of antacid medicine contain a class of drugs known as alginates. To assist preserve the membrane of the gullet (oesophagus) from digestive juices, alginates are administered. Sodium alginate and alginic acid are examples of alginates. They can be found in antacid drugs with a variety of brand names.

In 2021, the worldwide antacids market is worth 6.35 billion. According to IMARC Group, the industry would achieve revenue of Approximately 8.27 billion by 2027, with a CAGR of 4.20 percent between 2022 and 2027. We're constantly watching and analyzing the direct and indirect effects of COVID-19 on various end-use businesses, bearing in view the pandemic's uncertainty. As a prominent market participant, these data are incorporated into the research.

Sales of antacids that are used in balancing stomach acid to treat heartburn, acid reflux, and indigestion, make up the antacids market. Proton pump inhibitors, H2 antagonists, surgical simulators, and acid neutralizers are among the pharmacological classes that are available in tablet, liquid, or powder. Maalox, Alka Seltzer, Pepto-Bismol, Mylanta, Tums, Rolaids, etc are instances of antacids.

The FDA has mandated that antacid manufacturers in the United States and India follow the CFR - Code of Federal Regulations Title 21. According to these rules, an over-the-counter (OTC) acid medication in a form suitable for orally administered is only considered effective and safe if it meets the regulating body's requirements for active components.

GlaxoSmithKline plc, Bayer AG, Pfizer Inc., AstraZeneca PLC , Dr. Reddy's Laboratories Ltd, etc are major players in the antacids industry, as are, Sun Pharmaceuticals Industries Ltd, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Limited Wellspring Pharma, and Abbott Laboratories.

H2 antagonists, Proton pump inhibitors, acid ammonium bicarbonate, pro-motility agents, etc are the most common types of antacids. Proton-pump inhibitors are a class of medicine that dramatically and long-term lowers production of stomach acid. They achieve this by irreversibly inhibiting the K/H++ ATPase protons pump in the stomach. Tablets, liquids, powders, and other preparations are available, and they are delivered through a variety of channels including hospital pharmacies, and others.

At a compound annual growth (CAGR) of 6.1 percent, the global antacids market is predicted to increase from $8.60 billion in 2021 to $9.13 billion in 2022. Organizations are reorganizing their operations and recuperating from the COVID-19 impact, which had previously resulted in tight countermeasures such as lack of familiarity, remote working, and the shutdown of business activities, all of which created operational issues. At a CAGR of 4.4 percent, the international antacid market is estimated to reach $10.84 billion in 2026.

1. Market Dynamics for Antacids

One of the key factors driving the currency's development is the increasing incidence of gastroesophageal reflux disease (GERD). Antacids medicines are frequently used since they are inexpensive and help to relieve the irritation, stiffness, pain, and irritation caused by heartburn. Modern lifestyles, such as inconsistent diet and lifestyle, sleeping habits, and sedentary lives, are positively affecting the market growth in line with this. Furthermore, significant product advancements, including the introduction of safe raft-forming antacids and strong drugs with greater potency and long-acting, are propelling the industry forward.

As per the 2019 update of the Globe Population Estimates, by 2050, one in every six people around the world should be over the age of 65 (16%), up from one in every eleven people in 2019. Furthermore, every Antacid Medicines Manufacturer in India is concentrating on R&D efforts to bring innovative and trustworthy goods to market, as well as new products.

2. Competitive Environment

Because of the existence of multinationals and small-medium enterprises entering the market, the Antacids market is expected to register, and the total market will encounter severe rivalry over the projection period. Johnson & Johnson, GlaxoSmithKline plc, Sanofi S.A., Bayer AG, and Sun Pharmaceuticals Ltd are among the market's leading players. The big players have implemented methods including such mergers and acquisitions, alliances, and collaborations to help companies extend their geographical reach while also strengthening their corporate positions.

3. Segmentation of the Market

From 2022 through 2027, IMARC Group presents a study of key developments in each sub-segment of the worldwide antacids industry, as well as projections at the global, region, and national levels. The market is classified by class of drugs, formulations type, and channel of distribution in our research.

Classification of Drugs:

Inhibitors of the proton pump
Antagonist of H2
Neutralizers for Acid
Pro-Motility Substances

Analysis by Type of Implementation:

Tablet
Fluid
Powder
Others

Breakup by Distribution Channel:

Pharmacies in hospitals
Pharmacies in the Retail
Others

4. Latest Occurrences

Dr. Reddy's labs re-launched Structures comprising Tablets USP, 10 mg and 20 mg, over-the-counter (OTC) in the United States market in October 2020.

The approved equivalent for Horizon Therapeutics PLC's Vimovo (anti-inflammatories magnesium) delayed-release tablets was released in the United States by Lupin in March 2020. The antacid syrup is a mixture of esomeprazole magnesium and naproxen. Here, naproxen is used for symptom relief of orally ingested magnesium and arthritis that is used to reduce the risk of naproxen-associated stomach ulcers.

Antacid Tablet benefits

1. In terms of acidity

Antacid Tablets reduce acid reflux, which helps to prevent heartburn and heartburn. It is typically used in combination with other medications to treat your illness.

Continually take it for as long as your doctor suggests. To obtain the best benefit from this medicine, you must take it regularly. To stay hydrated, eat a fiber-rich diet, limit fatty or spicy foods, and drink lots of water while taking it.

2. In the case of stomach ulcer

Stomach problems are unpleasant sores that form in the stomach or intestine's inner lining (intestine). Antacid Tablets lower the oxidative stress caused by your stomach, preventing further ulcer damage as it recovers organically. Based on what created the ulcer, you may be prescribed additional medications in addition to this one. Even if your symptoms seem to vanish, you must continue to take Antacid Tablet as directed by your doctor for it to be successful.

3. In the case of bloating

Bloating is the accumulation of gas in the stomach as a result of irregular muscular activity in the stomach and intestines. Antacid Tablets assist avoid bloating by improving the flow of digestion.

For that to be effective, you must take it medication as directed. Bloating can be stopped or reduced by making a few easy lifestyle modifications. Eat properly, stay away from hot and oily foods, exercise for at least 30 minutes every day, and don't overeat.

Targeting Important Channels of distribution in India

Antacids market companies are focusing on sales channels including pharmacies, and online stores on an Indian stager.

Among these, the accessibility of antacids over-the-counter is moving profitable sales potential away from hospital pharmacists and toward others.

Online pharmacies are becoming a typical distribution route for antacid drugs, because of the remarkable rise of e-Commerce outlets and the comfort of home delivery of treatments. Consumer purchasing habits, on the other hand, differ by area.

India is the world's largest antacids market, with a share of one-third of the global market in 2027. Players in the antacids market across the globe are registering a majority of customers through online pharmacies, owing to the high popularity of mobile and the attractiveness of the online-shopping culture.

Conclusion

The drug class, formula, channel of distribution, and region-specific information, as well as sales volume estimate, are all included in this research on the Indian antacids market. It also includes an in-depth predicted price point analysis. Quotes from stakeholders in the Indian antacid tablets market were used to create the price index and effect analysis of major regional and country-level factors, which are also covered in the antacids market analysis.

FAQs: Antacids

Q. What is the market trend for antacids in India?

Ans. Over the following five years, the Indian Antacids Market is expected to increase at a CAGR of 3.7 percent.

Q. Is Digene an antacid or a laxative?

Ans. Yes! Medicinal Advantages Digene Mint Flavour Chewable Tablet 15's are antacids, which are used to cure acid reflux, indigestion, anxiety, gastritis (stomach irritation), and tummy distress.

Q. What is the market's CAGR for antacids?

Ans. The antacids market is expected to grow at a CAGR of 4% over the projected period, according to the analysis (2020-2027).

Q. Eno or Digene: which is stronger?

Ans. While most products provide comfort within minutes, any acidity can only provide comfort for up to 52 minutes. Eno Fruit Salt came out on top with 52-minute effectiveness, while Digene Gel and Dey's Milk of Magnesia inside the liquids division came in at 30 minutes.